At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

A study from Nationwide Children's Hospital suggests that a newly identified group of proteins, alpha arrestins, may play a role in cell signaling that is crucial to new drug development.

Olutayo Farinde, a synthetic organic and medicinal chemist at the University of Toledo, has disclosed that fast-tracking organic methodology can accelerate a cure.

From virtual monitoring and eConsent to AI-driven image analysis, technology is revolutionising the drug development pathway. And now that the evidence base is catching up with digital ...

Between 70% and 90% of drug ... molecular pathways involved in these disorders. Singh asserts that using AI to streamline the process is a “win-win” for all since the development phase ...

The 3rd Hippo Pathway Targeted Drug Development Summit has been built alongside industry experts from the likes of Vivace Therapeutics, Orion Pharma, Insilico Medicine and more to return as the ...